Carnegie Lake Advisors
RXST icon

Carnegie Lake Advisors’s RxSight RXST Stock Holding History

Carnegie Lake Advisors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$748K Sell
152,745
-2,000
-1% -$11.7K 0.27% 86
2026
Q2 		$746K Hold
154,745
– – 0.28% 82
2026
Q1 		$953K Sell
154,745
-7,100
-4% -$59K 0.38% 71
2025
Q4 		$1.69M Sell
161,845
-32,500
-17% -$326K 0.64% 36
2025
Q3 		$1.75M Buy
194,345
+87,345
+82% +$767K 0.67% 36
2025
Q2 		$1.39M Buy
+107,000
New +$1.61M 0.55% 50

Other funds holding RXST

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
IEQ Capital
IEQ Capital Foster City, California $23.5B AUM 29.01% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Carnegie Lake Advisors's RXST Position: Q3 2026 in Review

Carnegie Lake Advisors reduced its RxSight (RXST) stake by 1.3% in Q3 2026, selling an estimated $11.7K and leaving 152,745 shares worth $748K. The position accounts for 0.27% of the portfolio, ranked #86.

Carnegie Lake Advisors first reported a position in RXST in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.75M in Q3 2025. 57 funds tracked by Wall St. Rank hold RXST as of Q3 2026.

  • Carnegie Lake Advisors held 152,745 shares of RxSight worth $748K as of Q3 2026.
  • Carnegie Lake Advisors sold 2,000 RxSight shares in Q3 2026, an estimated $11.7K.
  • RxSight made up 0.27% of Carnegie Lake Advisors's portfolio in Q3 2026, its #86 holding.
  • Carnegie Lake Advisors first reported a position in RxSight in Q2 2025 and has held it in 6 quarters since.
  • Carnegie Lake Advisors's RxSight position peaked at $1.75M in Q3 2025.
  • 57 funds tracked by Wall St. Rank held RxSight as of Q3 2026.

Based on Carnegie Lake Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.